UNIGE document Scientific Article
previous document  unige:20696  next document
add to browser collection

Surgical management of hepatic neuroendocrine tumor metastasis: results from an international multi-institutional analysis

Mayo, Skye C.
de Jong, M. C.
Pulitano, C.
Clary, B. M.
Reddy, S. K.
Gamblin, T. C.
Celinksi, S. A.
Kooby, D. A.
show hidden authors show all authors [1 - 21]
Published in Annals of Surgical Oncology. 2010, vol. 17, no. 12, p. 3129-3136
Abstract BACKGROUND: Management of neuroendocrine tumor liver metastasis (NELM) remains controversial, with some advocating an aggressive surgical approach while others have adopted a more conservative strategy. We sought to define the efficacy of the surgical management of NELM in a large multicenter international cohort of patients. METHODS: We identified 339 patients who underwent surgical management for NELM from 1985 to 2009 from an international database of eight major hepatobiliary centers. Relevant clinicopathologic data were assessed using Kaplan-Meier and Cox regression models. RESULTS: Most patients had a pancreatic (40%) or small bowel (25%) neuroendocrine tumor (NET) primary. The majority of patients (60%) had bilateral liver disease. At surgery, 78% of patients underwent hepatic resection, 3% ablation alone, and 19% resection + ablation. Major hepatectomy was performed in 45% of patients, and 14% underwent a second liver operation. Carcinoid was the most common NET histological subtype (53%). Median survival was 125 months, with overall 5- and 10-year survival of 74%, and 51%, respectively. Disease recurred in 94% of patients at 5 years. Patients with hormonally functional NET who had R0/R1 resection benefited the most from surgery (P = 0.01). On multivariate analyses, synchronous disease [hazard ratio (HR) = 1.9], nonfunctional NET hormonal status (HR = 2.0), and extrahepatic disease (HR = 3.0) remained predictive of worse survival (all P < 0.05). CONCLUSIONS: Liver-directed surgery for NELM is associated with prolonged survival; however, the majority of patients will develop recurrent disease. Patients with hormonally functional hepatic metastasis without prior extrahepatic or synchronous disease derive the greatest survival benefit from surgical management.
Keywords Cohort StudiesFemale*HepatectomyHumansInternational AgenciesLiver Neoplasms/secondary/*surgeryMaleMiddle AgedNeoplasm StagingNeuroendocrine Tumors/pathology/*surgerySurvival RateTreatment Outcome
PMID: 20585879
Full text
Article - document accessible for UNIGE members only Limited access to UNIGE
Other version: http://www.springerlink.com/content/112644/
Research group Hépatologie chirurgicale (327)
(ISO format)
MAYO, Skye C. et al. Surgical management of hepatic neuroendocrine tumor metastasis: results from an international multi-institutional analysis. In: Annals of Surgical Oncology, 2010, vol. 17, n° 12, p. 3129-3136. doi: 10.1245/s10434-010-1154-5 https://archive-ouverte.unige.ch/unige:20696

454 hits

0 download


Deposited on : 2012-05-23

Export document
Format :
Citation style :